マイクロニードルドラッグデリバリーシステムの世界市場2020年-2030年

◆英語タイトル:Microneedle Drug Delivery Systems Market Forecast, Trend Analysis & Opportunity Assessment 2020-2030
◆商品コード:FMI21FB08
◆発行会社(リサーチ会社):Future Market Insights
◆発行日:2020年11月9日
◆ページ数:238
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Individual Price(1名様閲覧用)USD5,000 ⇒換算¥570,000見積依頼/購入/質問フォーム
Corporate Price(同一法人内共有可)USD7,500 ⇒換算¥855,000見積依頼/購入/質問フォーム
Enterprise Price(複数拠点内共有可)USD10,000 ⇒換算¥1,140,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はFuture Market Insights社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Future Market Insights社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、マイクロニードルドラッグデリバリーシステムの世界市場について調査・分析し、エグゼクティブサマリー、市場概要、主要市場動向、主要成功要因、新型コロナウイルス感染症による危機分析、販売分析・予測、価格分析、需要分析・予測、市場背景、製品タイプ別(中空マイクロニードル、固体マイクロニードル、溶解性マイクロニードル)分析、エンドユーザー別(病院、外来手術センター、専門クリニック、学術機関、研究機関)分析、地域別分析、市場構造分析、競争分析、仮定、調査手法等の項目を掲載しています。
・エグゼクティブサマリー
・市場概要
・主要市場動向
・主要成功要因
・新型コロナウイルス感染症による危機分析
・販売分析・予測
・価格分析
・需要分析・予測
・市場背景
・マイクロニードルドラッグデリバリーシステムの世界市場規模:製品タイプ別(中空マイクロニードル、固体マイクロニードル、溶解性マイクロニードル)
・マイクロニードルドラッグデリバリーシステムの世界市場規模:エンドユーザー別(病院、外来手術センター、専門クリニック、学術機関、研究機関)
・マイクロニードルドラッグデリバリーシステムの世界市場規模:地域別
・市場構造分析
・競争分析
・仮定
・調査手法
【レポートの概要】

A recent market study published by Future Market Insights (FMI) on the microneedle drug delivery systems market includes global industry analysis for 2015-2019 & opportunity assessment for 2020-2030, delivers a comprehensive assessment of the most important market dynamics. After conducting a thorough research on the historical as well as current growth parameters of the microneedle drug delivery systems market, growth prospects are obtained with maximum precision.

Microneedle Drug Delivery Systems Market: Segmentation

The global microneedle drug delivery systems market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

Product Type
Solid Microneedles
Silicon
Metal
Polymer
Hollow Microneedles
Dissolving Microneedles

End User
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Academic Institutions
Research institutes

Region
North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East & Africa

Report Chapters

Chapter 01 – Executive Summary

The report initiates with the executive summary of the microneedle drug delivery systems market, which includes a summary of key findings and statistics of the market. It also includes market size and revenue distribution of market segment of the microneedle drug delivery systems market.

Chapter 02 – Market Overview

Readers can find the definition and a detailed segmentation of the microneedle drug delivery systems market in this chapter, which will help them understand the basic information about the market.

Chapter 03 – Key Market Trends

This chapter highlights the key trends impacting the growth of the microneedle drug delivery systems market over the forecast period. This chapter helps reader to understand the trends of microneedle drug delivery systems market.

Chapter 04 ­– Key Success Factors

This section includes key success factors such as product adoption analysis, application road map, key promotional strategies, regulations, and many more. This section helps readers understand the key factors associated with the microneedle drug delivery systems market.

Chapter 05 – Global Microneedle Drug Delivery Systems Market: COVID19 Crisis Analysis

This section highlights COVID19 crisis analysis that are expected to influence growth of the microneedle drug delivery systems market over the forecast period. This section helps reader to understand the COVID19 crisis analysis in various geography.

Chapter 06 – Global Microneedle Drug Delivery Systems Market Volume (Units) Analysis 2015-2019 & Opportunity Assessment 2020-2030

This section explains the global market Volume (Units) analysis and forecast for the microneedle drug delivery systems market during the forecast period. This chapter includes a detailed analysis of the historical microneedle drug delivery systems market, along with an opportunity analysis of the future. Readers can also find the absolute $ opportunity for the current year (2020), and an incremental $ opportunity for the forecast period (2020–2030).

Chapter 07 – Global Microneedle Drug Delivery Systems Market: Pricing Analysis

This section highlights the global microneedle drug delivery systems market pricing analysis by Product type. This section helps reader to understand the pricing variation of whole slide scanner in various geography.

Chapter 08 – Global Microneedle Drug Delivery Systems Market Value Analysis 2015-2019 & Opportunity Assessment 2020-2030

This section explains the global market value analysis and forecast for the microneedle drug delivery systems market during the forecast period. This chapter includes a detailed analysis of the historical microneedle drug delivery systems market, along with an opportunity analysis of the future. Readers can also find the absolute $ opportunity for the current year (2020), and an incremental $ opportunity for the forecast period (2020–2030).

Chapter 09 – Market Background

This chapter explains the key macroeconomic factors, drivers, restraints, and opportunity analysis that are expected to influence growth of the microneedle drug delivery systems market over the forecast period. Moreover, in-depth information about the market dynamics and their impact analysis on the market have been provided in the successive section.

Chapter 10 – Global Microneedle drug delivery systems market Analysis 2015-2019 & Opportunity Assessment 2020-2030, by Product Type

Based on product type, the microneedle drug delivery systems market is segmented into solid microneedles, hollow microneedles and dissolving microneedles. In this chapter, readers can find information about the key trends and developments in microneedle drug delivery systems market and market attractiveness analysis based on product type.

Chapter 11 – Global Microneedle drug delivery systems market Analysis 2015-2019 & Opportunity Assessment 2020-2030, by End User

This chapter provides details about the microneedle drug delivery systems market based on end user, and has been classified into hospitals, ambulatory surgical centers, specialty clinics, academic institutes and research institutes. In this chapter, readers can understand the market attractiveness analysis based on end user.

Chapter 12 – Global Microneedle drug delivery systems market Analysis 2015-2019 & Opportunity Assessment 2020-2030, by Region

This chapter explains how the microneedle drug delivery systems market will grow across various geographic regions such as North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa (MEA).

Chapter 13 – North America Microneedle drug delivery systems market Analysis 2015-2019 & Opportunity Assessment 2020-2030

This chapter includes a detailed analysis of growth of the North America microneedle drug delivery systems market, along with a country-wise assessment that includes the U.S. and Canada. Readers can also find the regional trends, and market growth based on the application and countries in North America.

Chapter 14 – Latin America Microneedle Drug Delivery Systems Market Analysis 2015-2019 & Opportunity Assessment 2020-2030

This chapter provides the growth scenario of the microneedle drug delivery systems market in Latin American countries such as Argentina, Brazil, Mexico, and the Rest of Latin America. Along with this, assessment of the market across target segments has been provided.

Chapter 15 –Europe Microneedle Drug Delivery Systems Market Analysis 2015-2019 & Opportunity Assessment 2020-2030

This chapter provides the growth scenario of the microneedle drug delivery systems market in Europe in several countries such as Germany, U.K., France, Spain, Italy, Russia, and the Rest of Europe are included in this chapter.

Chapter 16 – South Asia Microneedle Drug Delivery Systems Market Analysis 2015-2019 & Opportunity Assessment 2020-2030

This chapter provides the growth scenario of the microneedle drug delivery systems market in South Asia in several countries such as India, Thailand, Indonesia, Malaysia and rest of South Asia are included in this chapter.

Chapter 17 – East Asia Microneedle Drug Delivery Systems Market Analysis 2015-2019 & Opportunity Assessment 2020-2030

This chapter highlights the growth of the microneedle drug delivery systems market in East Asia by focusing on China, Japan & South Korea. This section also help readers understand the key factors that are responsible for the growth of the microneedle drug delivery systems market in East Asia.

Chapter 18 – Oceania Microneedle Drug Delivery Systems Market Analysis 2015-2019 & Opportunity Assessment 2020-2030

This chapter highlights the growth of the microneedle drug delivery systems market in Oceania. This section also help readers understand the key factors that are responsible for the growth of the microneedle drug delivery systems market in Australia and New Zealand.

Chapter 19 – MEA Microneedle Drug Delivery Systems Market Analysis 2015-2019 & Opportunity Assessment 2020-2030

This chapter provides information about how the microneedle drug delivery systems market will grow in major countries in the MEA region such as GCC Countries, South Africa, Turkey and the Rest of MEA, during the forecast period.

Chapter 20– Key and Emerging Countries Analysis

This section include deep dive analysis of microneedle drug delivery systems market for key and emerging countries. Reader can understand the market value and volume by product type, end user for key countries.

Chapter 21 – Market Structure Analysis

This chapter highlights the tier structure analysis, market concentration analysis and company share analysis along with sales footprint analysis of key player operating in microneedle drug delivery systems market.

Chapter 22 – Competition Analysis

In this chapter, readers can find a comprehensive list of all the prominent stakeholders in the microneedle drug delivery systems market, along with a detailed information about each company, which includes company overview, revenue shares, strategic overview, and recent company developments. Some of the market players featured in the report are the 3M Company, Becton, Dickinson and Company, Zosano Pharma Corporation, Raphas Co., Ltd., Nanopass Tech, Corium International, Inc., Valeritas, Inc., Nitto Denko Corporation, Microdermics Inc., TheraJect, Inc., Vaxxas Pty Ltd., Endoderma Ltd., QuadMedicine, SNvia Co., Ltd., Small Lab, and AdminMed nanoBioSciences LLC.

Chapter 23 – Assumptions and Acronyms

This chapter includes a list of acronyms and assumptions that provides a base to the information and statistics included in the microneedle drug delivery systems market report.

Chapter 24 – Research Methodology

This chapter help readers understand the research component methodology followed to obtain various conclusions as well as important qualitative and quantitative information about the microneedle drug delivery systems market.

【レポートの目次】

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand Side Trends

1.3. Supply Side Trends

1.4. Technology Roadmap

1.5. Analysis and Recommendations

1.6. Transdermal Drug Delivery System Market

1.6.1. Global Market Overview (including Market Size)

1.6.2. Future Growth Prospect & Strategic Outlook

1.6.3. Opportunities (in terms of revenue generation)

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

3. Key Market Trends

3.1. Key Trends Impacting The Market

3.2. Advancement in Tissue Diagnostics

4. Key Success Factors

4.1. Product USPs and Adoption

4.2. Promotional Strategies, by Key Manufacturers

4.3. Patent Analysis

4.4. Clinical Trial Analysis

4.4.1. Clinical Trials by Region

4.4.2. Analysis by Sponsor Type

4.4.3. Analysis by Trial Phase

4.5. Key Regulations

4.6. Key Industry Deals

4.7. Key Epidemiology of Needle Phobic Population

5. COVID19 Crisis Analysis

5.1. Current COVID19 Statistics and Probable Future Impact

5.2. Current GDP Projection and Probable Impact

5.3. Current Economic Projection as compared to 2008 financial analysis

5.4. COVID19 and Impact Analysis

5.4.1. Revenue By Product Type

5.4.2. Revenue By Country

5.5. 2020 Market Scenario

5.6. Quarter by Quarter Forecast

5.7. Projected recovery Quarter

5.8. Recovery Scenario – Short term, Midterm and Long Term Impact

6. Global Microneedle Drug Delivery Systems Market Sales Analysis 2015-2019 and Forecast, 2020-2030

6.1. Historical Market Volume (Mn Units) Analysis, 2015-2019

6.2. Y-o-Y Growth Trend Analysis

7. Global Microneedle Drug Delivery Systems Market – Pricing Analysis

7.1. Regional Pricing Analysis, By Distribution Channel

7.2. Global Average Pricing Analysis Benchmark

8. Global Microneedle Drug Delivery Systems Market Demand (in Value or Size in US$ Mn) Analysis 2015-2019 and Forecast, 2020–2030

8.1. Historical Market Value (US$ Mn) Analysis, 2015-2019

8.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030

8.2.1. Y-o-Y Growth Trend Analysis

8.2.2. Absolute $ Opportunity Analysis

9. Market Background

9.1. Macro-Economic Factors

9.1.1. Global GDP Growth Outlook

9.1.2. Global Healthcare Expenditure Outlook

9.1.3. Growth of Healthcare Sector in Emerging nations

9.2. Forecast Factors – Relevance & Impact

9.2.1. Disease Incidence/Prevalence Rate

9.2.2. COVID 19 Pandemic Impact

9.2.3. Top Companies Historical Growth

9.2.4. Frequency of New Product Launches

9.2.5. Treatment Cost (Microneedle Drug Delivery Systems)

9.2.6. Per Patient Spending

9.3. Market Dynamics

9.3.1. Drivers

9.3.2. Restraints

9.3.3. Opportunity Analysis

10. Global Microneedle Drug Delivery Systems Market Analysis 2015-2019 and Forecast 2020-2030, By Product Type

10.1. Introduction / Key Findings

10.2. Historical Market Size (US$ Mn) and Volume Analysis By Product Type, 2015 – 2019

10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2020 – 2030

10.3.1. Hollow Microneedles

10.3.2. Solid Microneedles

10.3.2.1. Silicon

10.3.2.2. Metal

10.3.2.3. Polymer

10.3.3. Dissolving Microneedles

10.4. Market Attractiveness Analysis By Product Type

11. Global Microneedle Drug Delivery Systems 2015-2019 and Forecast 2020-2030, by End Users

11.1. Introduction / Key Findings

11.2. Historical Market Size (US$ Mn) Analysis By End Users, 2015 – 2019

11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End Users, 2019 – 2019

11.3.1. Hospitals

11.3.2. Ambulatory Surgical Centers

11.3.3. Specialty Clinics

11.3.4. Academic Institutions

11.3.5. Research Institutes

11.4. Market Attractiveness Analysis By End Users

12. Global Microneedle Drug Delivery Systems Market Analysis 2015-2019 and Forecast 2020-2030, by Region

12.1. Introduction

12.2. Historical Market Size (US$ Mn) and Volume Analysis By Region, 2015 – 2019

12.3. Current Market Size (US$ Mn) and Volume Analysis and Forecast By Region, 2019 – 2019

12.3.1. North America

12.3.2. Latin America

12.3.3. Europe

12.3.4. Middle East and Africa (MEA)

12.3.5. East Asia

12.3.6. South Asia

12.3.7. Oceania

12.4. Market Attractiveness Analysis By Region

13. North America Microneedle Drug Delivery Systems Market Analysis 2015-2019 and Forecast 2020-2030

13.1. Introduction

13.2. Pricing Analysis

13.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015 – 2019

13.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020 – 2030

13.4.1. By Country

13.4.1.1. U.S.

13.4.1.2. Canada

13.4.2. By Product Type

13.4.3. By End Users

13.5. Market Attractiveness Analysis

13.6. Key Market Participants – Intensity Mapping

13.7. Drivers and Restraints – Impact Analysis

14. Latin America Microneedle Drug Delivery Systems Market Analysis 2015-2019 and Forecast 2020-2030

14.1. Introduction

14.2. Pricing Analysis

14.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015 – 2019

14.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020 – 2030

14.4.1. By Country

14.4.1.1. Brazil

14.4.1.2. Mexico

14.4.1.3. Argentina

14.4.1.4. Rest of Latin America

14.4.2. By Product Type

14.4.3. By End Users

14.5. Market Attractiveness Analysis

14.6. Key Market Participants – Intensity Mapping

14.7. Drivers and Restraints – Impact Analysis

15. Europe Microneedle Drug Delivery Systems Market Analysis 2015-2019 and Forecast 2020-2030

15.1. Introduction

15.2. Pricing Analysis

15.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015 – 2019

15.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020 – 2030

15.4.1. By Country

15.4.1.1. Germany

15.4.1.2. Italy

15.4.1.3. France

15.4.1.4. U.K.

15.4.1.5. Spain

15.4.1.6. BENELUX

15.4.1.7. Russia

15.4.1.8. Rest of Europe

15.4.2. By Technology

15.4.3. By End Users

15.5. Market Attractiveness Analysis

15.6. Key Market Participants – Intensity Mapping

15.7. Drivers and Restraints – Impact Analysis

16. South Asia Microneedle Drug Delivery Systems Market Analysis 2015-2019 and Forecast 2020-2030

16.1. Introduction

16.2. Pricing Analysis

16.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015 – 2019

16.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020 – 2030

16.4.1. By Country

16.4.1.1. India

16.4.1.2. Thailand

16.4.1.3. Indonesia

16.4.1.4. Malaysia

16.4.1.5. Rest of South Asia

16.4.2. By Product Type

16.4.3. By End Users

16.5. Market Attractiveness Analysis

16.6. Key Market Participants – Intensity Mapping

16.7. Drivers and Restraints – Impact Analysis

17. East Asia Microneedle Drug Delivery Systems Market Analysis 2015-2019 and Forecast 2020-2030

17.1. Introduction

17.2. Pricing Analysis

17.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015 – 2019

17.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020 – 2030

17.4.1. By Country

17.4.1.1. China

17.4.1.2. Japan

17.4.1.3. South Korea

17.4.2. By Product Type

17.4.3. By End Users

17.5. Market Attractiveness Analysis

17.6. Key Market Participants – Intensity Mapping

17.7. Drivers and Restraints – Impact Analysis

18. Oceania Microneedle Drug Delivery Systems Market Analysis 2015-2019 and Forecast 2020-2030

18.1. Introduction

18.2. Pricing Analysis

18.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015 – 2019

18.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020 – 2030

18.4.1. By Country

18.4.1.1. Australia

18.4.1.2. New Zealand

18.4.2. By Product Type

18.4.3. By End Users

18.5. Market Attractiveness Analysis

18.6. Key Market Participants – Intensity Mapping

18.7. Drivers and Restraints – Impact Analysis

19. Middle East and Africa Market Analysis Microneedle Drug Delivery Systems 2015-2019 and Forecast 2020-2030

19.1. Introduction

19.2. Pricing Analysis

19.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015 – 2019

19.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020 – 2030

19.4.1. By Country

19.4.1.1. GCC Countries

19.4.1.2. South Africa

19.4.1.3. Rest of Middle East and Africa

19.4.2. By Product Type

19.4.3. By End Users

19.5. Market Attractiveness Analysis

19.6. Key Market Participants – Intensity Mapping

19.7. Drivers and Restraints – Impact Analysis

20. Key and Emerging Countries Microneedle Drug Delivery Systems Market Analysis 2015-2019 and Forecast 2020-2030

20.1. Introduction

20.1.1. Market Value Proportion Analysis, By Key Countries

20.1.2. Global Vs. Country Growth Comparison

20.2. U.S. Microneedle Drug Delivery Systems Market Analysis

20.2.1. By Product Type

20.2.2. By End User

20.3. Canada Microneedle Drug Delivery Systems Market Analysis

20.3.1. By Product Type

20.3.2. By End User

20.4. Mexico Microneedle Drug Delivery Systems Market Analysis

20.4.1. By Product Type

20.4.2. By End User

20.5. Brazil Microneedle Drug Delivery Systems Market Analysis

20.5.1. By Product Type

20.5.2. By End User

20.6. U.K. Microneedle Drug Delivery Systems Market Analysis

20.6.1. By Product Type

20.6.2. By End User

20.7. Germany Microneedle Drug Delivery Systems Market Analysis

20.7.1. By Product Type

20.7.2. By End User

20.8. France Microneedle Drug Delivery Systems Market Analysis

20.8.1. By Product Type

20.8.2. By End User

20.9. Italy Microneedle Drug Delivery Systems Market Analysis

20.9.1. By Product Type

20.9.2. By End User

20.10. Spain Microneedle Drug Delivery Systems Market Analysis

20.10.1. By Product Type

20.10.2. By End User

20.11. BENELUX Microneedle Drug Delivery Systems Market Analysis

20.11.1. By Product Type

20.11.2. By End User

20.12. Russia Microneedle Drug Delivery Systems Market Analysis

20.12.1. By Product Type

20.12.2. By End User

20.13. China Microneedle Drug Delivery Systems Market Analysis

20.13.1. By Product Type

20.13.2. By End User

20.14. Japan Microneedle Drug Delivery Systems Market Analysis

20.14.1. By Product Type

20.14.2. By End User

20.15. South Korea Microneedle Drug Delivery Systems Market Analysis

20.15.1. By Product Type

20.15.2. By End User

20.16. India Microneedle Drug Delivery Systems Market Analysis

20.16.1. By Product Type

20.16.2. By End User

20.17. ASEAN Microneedle Drug Delivery Systems Market Analysis

20.17.1. By Product Type

20.17.2. By End User

20.18. Australia Microneedle Drug Delivery Systems Market Analysis

20.18.1. By Product Type

20.18.2. By End User

20.19. New Zealand Microneedle Drug Delivery Systems Market Analysis

20.19.1. By Product Type

20.19.2. By End User

20.20. GCC Countries Microneedle Drug Delivery Systems Market Analysis

20.20.1. By Product Type

20.20.2. By End User

20.21. Turkey Microneedle Drug Delivery Systems Market Analysis

20.21.1. By Product Type

20.21.2. By End User

20.22. South Africa Microneedle Drug Delivery Systems Market Analysis

20.22.1. By Product Type

20.22.2. By End User

21. Market Structure Analysis

21.1. Market Analysis by Tier of Companies (Real-Time Bioprocess Raman Analyzer )

21.2. Market Concentration

21.3. Market Share Analysis of Top Players

21.4. Market Presence Analysis

21.4.1. By Regional Footprint of Players

21.4.2. Product Footprint by Players

21.4.3. Channel Footprint by Players

22. Competition Analysis

22.1. Competition Dashboard

22.2. Pricing Analysis by Competition

22.3. Competition Benchmarking

22.4. Competition Deep Dive

22.4.1. The 3M Company

22.4.1.1. Overview

22.4.1.2. Product Portfolio

22.4.1.2.1. In-depth Product Analysis

22.4.1.3. Pipeline Assessment

22.4.1.3.1. Microneedle Drug Pipeline

22.4.1.3.2. Clinical Trial Analysis

22.4.1.4. Sales Footprint

22.4.1.5. Analyst Commentary

22.4.2. Becton, Dickinson and Company (BD)

22.4.2.1. Overview

22.4.2.2. Product Portfolio

22.4.2.2.1. In-depth Product Analysis

22.4.2.3. Pipeline Assessment

22.4.2.3.1. Microneedle Drug Pipeline

22.4.2.3.2. Clinical Trial Analysis

22.4.2.4. Sales Footprint

22.4.2.5. Analyst Commentary

22.4.3. Zosano Pharma Corporation

22.4.3.1. Overview

22.4.3.2. Product Portfolio

22.4.3.2.1. In-depth Product Analysis

22.4.3.3. Pipeline Assessment

22.4.3.3.1. Microneedle Drug Pipeline

22.4.3.3.2. Clinical Trial Analysis

22.4.3.4. Sales Footprint

22.4.3.5. Analyst Commentary

22.4.4. Raphas Co., Ltd.

22.4.4.1. Overview

22.4.4.2. Product Portfolio

22.4.4.2.1. In-depth Product Analysis

22.4.4.3. Pipeline Assessment

22.4.4.3.1. Microneedle Drug Pipeline

22.4.4.3.2. Clinical Trial Analysis

22.4.4.4. Sales Footprint

22.4.4.5. Analyst Commentary

22.4.5. Nanopass Tech

22.4.5.1. Overview

22.4.5.2. Product Portfolio

22.4.5.2.1. In-depth Product Analysis

22.4.5.3. Pipeline Assessment

22.4.5.3.1. Microneedle Drug Pipeline

22.4.5.3.2. Clinical Trial Analysis

22.4.5.4. Sales Footprint

22.4.5.5. Analyst Commentary

22.4.6. Corium International, Inc.

22.4.6.1. Overview

22.4.6.2. Product Portfolio

22.4.6.2.1. In-depth Product Analysis

22.4.6.3. Pipeline Assessment

22.4.6.3.1. Microneedle Drug Pipeline

22.4.6.3.2. Clinical Trial Analysis

22.4.6.4. Sales Footprint

22.4.6.5. Analyst Commentary

22.4.7. Valeritas, Inc.

22.4.7.1. Overview

22.4.7.2. Product Portfolio

22.4.7.2.1. In-depth Product Analysis

22.4.7.3. Pipeline Assessment

22.4.7.3.1. Microneedle Drug Pipeline

22.4.7.3.2. Clinical Trial Analysis

22.4.7.4. Sales Footprint

22.4.7.5. Analyst Commentary

22.4.8. Nitto Denko Corporation

22.4.8.1. Overview

22.4.8.2. Product Portfolio

22.4.8.2.1. In-depth Product Analysis

22.4.8.3. Pipeline Assessment

22.4.8.3.1. Microneedle Drug Pipeline

22.4.8.3.2. Clinical Trial Analysis

22.4.8.4. Sales Footprint

22.4.8.5. Analyst Commentary

22.4.9. Microdermics Inc.

22.4.9.1. Overview

22.4.9.2. Product Portfolio

22.4.9.2.1. In-depth Product Analysis

22.4.9.3. Pipeline Assessment

22.4.9.3.1. Microneedle Drug Pipeline

22.4.9.3.2. Clinical Trial Analysis

22.4.9.4. Sales Footprint

22.4.9.5. Analyst Commentary

22.4.10. TheraJect, Inc.

22.4.10.1. Overview

22.4.10.2. Product Portfolio

22.4.10.2.1. In-depth Product Analysis

22.4.10.3. Pipeline Assessment

22.4.10.3.1. Microneedle Drug Pipeline

22.4.10.3.2. Clinical Trial Analysis

22.4.10.4. Sales Footprint

22.4.10.5. Analyst Commentary

22.4.11. Vaxxas Pty Ltd.

22.4.11.1. Overview

22.4.11.2. Product Portfolio

22.4.11.2.1. In-depth Product Analysis

22.4.11.3. Pipeline Assessment

22.4.11.3.1. Microneedle Drug Pipeline

22.4.11.3.2. Clinical Trial Analysis

22.4.11.4. Sales Footprint

22.4.11.5. Analyst Commentary

22.4.12. Endoderma Ltd.

22.4.12.1. Overview

22.4.12.2. Product Portfolio

22.4.12.2.1. In-depth Product Analysis

22.4.12.3. Pipeline Assessment

22.4.12.3.1. Microneedle Drug Pipeline

22.4.12.3.2. Clinical Trial Analysis

22.4.12.4. Sales Footprint

22.4.12.5. Analyst Commentary

22.4.13. QuadMedicine

22.4.13.1. Overview

22.4.13.2. Product Portfolio

22.4.13.2.1. In-depth Product Analysis

22.4.13.3. Pipeline Assessment

22.4.13.3.1. Microneedle Drug Pipeline

22.4.13.3.2. Clinical Trial Analysis

22.4.13.4. Sales Footprint

22.4.13.5. Analyst Commentary

22.4.14. SNvia Co., Ltd.

22.4.14.1. Overview

22.4.14.2. Product Portfolio

22.4.14.2.1. In-depth Product Analysis

22.4.14.3. Pipeline Assessment

22.4.14.3.1. Microneedle Drug Pipeline

22.4.14.3.2. Clinical Trial Analysis

22.4.14.4. Sales Footprint

22.4.14.5. Analyst Commentary

22.4.15. Small Lab

22.4.15.1. Overview

22.4.15.2. Product Portfolio

22.4.15.2.1. In-depth Product Analysis

22.4.15.3. Pipeline Assessment

22.4.15.3.1. Microneedle Drug Pipeline

22.4.15.3.2. Clinical Trial Analysis

22.4.15.4. Sales Footprint

22.4.15.5. Analyst Commentary

22.4.16. AdminMed nanoBioSciences LLC

22.4.16.1. Overview

22.4.16.2. Product Portfolio

22.4.16.2.1. In-depth Product Analysis

22.4.16.3. Pipeline Assessment

22.4.16.3.1. Microneedle Drug Pipeline

22.4.16.3.2. Clinical Trial Analysis

22.4.16.4. Sales Footprint

22.4.16.5. Analyst Commentary

23. Assumptions and Acronyms Use

24. Research Methodology

Table 01: Global Microneedle Drug Delivery Device Market Volume (‘000 Units) Analysis and Opportunity Assessment 2015–2030, By Product Type

Table 02: Global Microneedle Drug Delivery Device Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Product Type

Table 03: Global Microneedle Drug Delivery Device Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By End User

Table 04: Global Microneedle Drug Delivery Device Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Region

Table 05: North America Microneedle Drug Delivery Device Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country

Table 06: North America Microneedle Drug Delivery Device Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Product Type

Table 07: North America Microneedle Drug Delivery Device Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By End User

Table 08: Latin America Microneedle Drug Delivery Device Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country

Table 09: Latin America Microneedle Drug Delivery Device Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Product Type

Table 10: Latin America Microneedle Drug Delivery Device Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By End User

Table 11: Europe Microneedle Drug Delivery Device Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country

Table 12: Europe Microneedle Drug Delivery Device Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Product Type

Table 13: Europe Microneedle Drug Delivery Device Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By End User

Table 14: South Asia Microneedle Drug Delivery Device Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country

Table 15: South Asia Microneedle Drug Delivery Device Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Product Type

Table 16: South Asia Microneedle Drug Delivery Device Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By End User

Table 17: East Asia Microneedle Drug Delivery Device Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country

Table 18: East Asia Microneedle Drug Delivery Device Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Product Type

Table 19: East Asia Microneedle Drug Delivery Device Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By End User

Table 20: Oceania Microneedle Drug Delivery Device Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country

Table 21: Oceania Microneedle Drug Delivery Device Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Product Type

Table 22: Oceania Microneedle Drug Delivery Device Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By End User

Table 23: MEA Microneedle Drug Delivery Device Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country

Table 24: MEA Microneedle Drug Delivery Device Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Product Type

Table 25: MEA Microneedle Drug Delivery Device Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By End User

Figure 01: Global Microneedle Drug Delivery Device Market Volume (in Mn Units) Analysis, 2015-2019

Figure 02: Global Microneedle Drug Delivery Device Market Volume Forecast (in Mn Units), 2020-2030

Figure 03: Solid microneedle drug delivery system Pricing Analysis (US$) for Per Unit, By Region, 2019

Figure 04: Hollow microneedle drug delivery system Pricing Analysis (US$) for Per Unit, By Region, 2019

Figure 05: Dissolving microneedle drug delivery system Pricing Analysis (US$) for Per Unit (Per Micron), By Region, 2019

Figure 06: Global Microneedle Drug Delivery Device Market Value Analysis (US$ Mn), 2015-2019

Figure 07: Global Microneedle Drug Delivery Device Market Value Forecast (US$ Mn), 2020-2030

Figure 08: Global Microneedle Drug Delivery Device Market Absolute $ Opportunity, 2020 – 2030

Figure 09: Global Microneedle Drug Delivery Device Market Share Analysis (%), By Product Type, 2020-2030

Figure 10: Global Microneedle Drug Delivery Device Market Y-o-Y Analysis (%), By Product Type, 2020-2030

Figure 11: Global Microneedle Drug Delivery Device Market Attractiveness Analysis By Product Type, 2020-2030

Figure 12: Global Microneedle Drug Delivery Device Market Share Analysis (%), By End User, 2020-2030

Figure 13: Global Microneedle Drug Delivery Device Market Y-o-Y Analysis (%), By End User, 2020-2030

Figure 14: Global Microneedle Drug Delivery Device Market Attractiveness Analysis By End User, 2020-2030

Figure 15: Global Microneedle Drug Delivery Device Market Share Analysis (%), By Region, 2020-2030

Figure 16: Global Microneedle Drug Delivery Device Market Y-o-Y Analysis (%), By Region, 2020-2030

Figure 17: Global Microneedle Drug Delivery Device Market Attractiveness Analysis By Region, 2020-2030

Figure 18: North America Microneedle Drug Delivery Device Market Value Share, By Product Type, 2020 (E)

Figure 19: North America Microneedle Drug Delivery Device Market Value Share, By End User, 2020 (E)

Figure 20: North America Microneedle Drug Delivery Device Market Value Share, By Country, 2020 (E)

Figure 21: North America Microneedle Drug Delivery Device Market Value Analysis (US$ Mn), 2015-2019

Figure 22: North America Microneedle Drug Delivery Device Market Value Forecast (US$ Mn), 2020-2030

Figure 23: North America Microneedle Drug Delivery Device Market Attractiveness Analysis By Product Type, 2020-2030

Figure 24: North America Microneedle Drug Delivery Device Market Attractiveness Analysis by End User, 2020-2030

Figure 25: North America Microneedle Drug Delivery Device Market Attractiveness Analysis by Country, 2020-2030

Figure 26: Latin America Microneedle Drug Delivery Device Market Value Share, By Product Type, 2020 (E)

Figure 27: Latin America Microneedle Drug Delivery Device Market Value Share, By End User, 2020 (E)

Figure 28: Latin America Microneedle Drug Delivery Device Market Value Share, By Country, 2020 (E)

Figure 29: Latin America Microneedle Drug Delivery Device Market Value Analysis (US$ Mn), 2015-2019

Figure 30: Latin America Microneedle Drug Delivery Device Market Value Forecast (US$ Mn), 2020-2030

Figure 31: Latin America Microneedle Drug Delivery Device Market Attractiveness Analysis By Product Type, 2020-2030

Figure 32: Latin America Microneedle Drug Delivery Device Market Attractiveness Analysis by End User, 2020-2030

Figure 33: Latin America Microneedle Drug Delivery Device Market Analysis by Country, 2020-2030

Figure 34: Europe Microneedle Drug Delivery Device Market Value Share, By Product Type, 2020 (E)

Figure 35: Europe Microneedle Drug Delivery Device Market Value Share, By End User, 2020 (E)

Figure 36: Europe Microneedle Drug Delivery Device Market Value Share, By Country, 2020 (E)

Figure 37: Europe Microneedle Drug Delivery Device Market Value Analysis (US$ Mn), 2015-2019

Figure 38: Europe Microneedle Drug Delivery Device Market Value Forecast (US$ Mn), 2020-2030

Figure 39: Europe Microneedle Drug Delivery Device Market Attractiveness Analysis By Product Type, 2020-2030

Figure 40: Europe Microneedle Drug Delivery Device Market Attractiveness Analysis by End User, 2020-2030

Figure 41: Europe Microneedle Drug Delivery Device Market Attractiveness Analysis by Country, 2020-2030

Figure 42: South Asia Microneedle Drug Delivery Device Market Value Share, By Product Type, 2020 (E)

Figure 43: South Asia Microneedle Drug Delivery Device Market Value Share, By End User, 2020 (E)

Figure 44: South Asia Microneedle Drug Delivery Device Market Value Share, By Country, 2020 (E)

Figure 45: South Asia Microneedle Drug Delivery Device Market Value Analysis (US$ Mn), 2015-2019

Figure 46: South Asia Microneedle Drug Delivery Device Market Value Forecast (US$ Mn), 2020-2030

Figure 47: South Asia Microneedle Drug Delivery Device Market Attractiveness Analysis By Product Type, 2020-2030

Figure 48: South Asia Microneedle Drug Delivery Device Market Attractiveness Analysis by End User, 2020-2030

Figure 49: South Asia Microneedle Drug Delivery Device Market Attractiveness Analysis by Country, 2020-2030

Figure 50: East Asia Microneedle Drug Delivery Device Market Value Share, By Product Type, 2020 (E)

Figure 51: East Asia Microneedle Drug Delivery Device Market Value Share, By End User, 2020 (E)

Figure 52: East Asia Microneedle Drug Delivery Device Market Value Share, By Country, 2020 (E)

Figure 53: East Asia Microneedle Drug Delivery Device Market Value Analysis (US$ Mn), 2015-2019

Figure 54: East Asia Microneedle Drug Delivery Device Market Value Forecast (US$ Mn), 2020-2030

Figure 55: East Asia Microneedle Drug Delivery Device Market Attractiveness Analysis By Product Type, 2020-2030

Figure 56: East Asia Microneedle Drug Delivery Device Market Attractiveness Analysis by End User, 2020-2030

Figure 57: East Asia Microneedle Drug Delivery Device Market Attractiveness Analysis by Country, 2020-2030

Figure 58: Oceania Microneedle Drug Delivery Device Market Value Share, By Product Type, 2020 (E)

Figure 59: Oceania Microneedle Drug Delivery Device Market Value Share, By End User, 2020 (E)

Figure 60: Oceania Microneedle Drug Delivery Device Market Value Share, By Country, 2020 (E)

Figure 61: Oceania Microneedle Drug Delivery Device Market Value Analysis (US$ Mn), 2015-2019

Figure 62: Oceania Microneedle Drug Delivery Device Market Value Forecast (US$ Mn), 2020-2030

Figure 63: Oceania Microneedle Drug Delivery Device Market Attractiveness Analysis By Product Type, 2020-2030

Figure 64:Oceania Microneedle Drug Delivery Device Market Attractiveness Analysis by End User, 2020-2030

Figure 65: Oceania Microneedle Drug Delivery Device Market Attractiveness Analysis by Country, 2020-2030

Figure 66: MEA Microneedle Drug Delivery Device Market Value Share, By Product Type, 2020 (E)

Figure 67: MEA Microneedle Drug Delivery Device Market Value Share, By End User, 2020 (E)

Figure 68: MEA Microneedle Drug Delivery Device Market Value Share, By Country, 2020 (E)

Figure 69: MEA Microneedle Drug Delivery Device Market Value Analysis (US$ Mn), 2015-2019

Figure 70: MEA Microneedle Drug Delivery Device Market Value Forecast (US$ Mn), 2020-2030

Figure 71: MEA Microneedle Drug Delivery Device Market Attractiveness Analysis By Product Type, 2020-2030

Figure 72: MEA Microneedle Drug Delivery Device Market Attractiveness Analysis by End User, 2020-2030

Figure 73: MEA Microneedle Drug Delivery Device Market Attractiveness Analysis by Country, 2020-2030

Figure 74: U. S. Microneedle Drug Delivery Device Market Value Share, By Product Type, 2020 (E)

Figure 75: U. S. Microneedle Drug Delivery Device Market Value Share, By End User, 2020 (E)

Figure 76: Canada Microneedle Drug Delivery Device Market Value Share, By Product Type, 2020 (E)

Figure 77: Canada Microneedle Drug Delivery Device Market Value Share, By End User, 2020 (E)

Figure 78: Mexico Microneedle Drug Delivery Device Market Value Share, By Product Type, 2020 (E)

Figure 79: Mexico Microneedle Drug Delivery Device Market Value Share, By End User, 2020 (E)

Figure 80: Brazil Microneedle Drug Delivery Device Market Value Share, By Product Type, 2020 (E)

Figure 81: Brazil Microneedle Drug Delivery Device Market Value Share, By End User, 2020 (E)

Figure 82: U.K. Microneedle Drug Delivery Device Market Value Share, By Product Type, 2020 (E)

Figure 83: U.K. Microneedle Drug Delivery Device Market Value Share, By End User, 2020 (E)

Figure 84: Germany Microneedle Drug Delivery Device Market Value Share, By Product Type, 2020 (E)

Figure 85: Germany Microneedle Drug Delivery Device Market Value Share, By End User, 2020 (E)

Figure 86: France Microneedle Drug Delivery Device Market Value Share, By Product Type, 2020 (E)

Figure 87: France Microneedle Drug Delivery Device Market Value Share, By End User, 2020 (E)

Figure 88: Italy Microneedle Drug Delivery Device Market Value Share, By Product Type, 2020 (E)

Figure 89: Italy Microneedle Drug Delivery Device Market Value Share, By End User, 2020 (E)

Figure 90: Spain Microneedle Drug Delivery Device Market Value Share, By Product Type, 2020 (E)

Figure 91: Spain Microneedle Drug Delivery Device Market Value Share, By End User, 2020 (E)

Figure 92: Russia Microneedle Drug Delivery Device Market Value Share, By Product Type, 2020 (E)

Figure 93: Russia Microneedle Drug Delivery Device Market Value Share, By End User, 2020 (E)

Figure 94: China Microneedle Drug Delivery Device Market Value Share, By Product Type, 2020 (E)

Figure 95: China Microneedle Drug Delivery Device Market Value Share, By End User, 2020 (E)

Figure 96: Japan Microneedle Drug Delivery Device Market Value Share, By Product Type, 2020 (E)

Figure 97: Japan Microneedle Drug Delivery Device Market Value Share, By End User, 2020 (E)

Figure 98: South Korea Microneedle Drug Delivery Device Market Value Share, By Product Type, 2020 (E)

Figure 99: South Korea Microneedle Drug Delivery Device Market Value Share, By End User, 2020 (E)

Figure 100: India Microneedle Drug Delivery Device Market Value Share, By Product Type, 2020 (E)

Figure 101: India Microneedle Drug Delivery Device Market Value Share, By End User, 2020 (E)

Figure 102: Thailand Microneedle Drug Delivery Device Market Value Share, By Product Type, 2020 (E)

Figure 103: Thailand Microneedle Drug Delivery Device Market Value Share, By End User, 2020 (E)

Figure 104: Indonesia Microneedle Drug Delivery Device Market Value Share, By Product Type, 2020 (E)

Figure 105: Indonesia Microneedle Drug Delivery Device Market Value Share, By End User, 2020 (E)

Figure 106: Malaysia Microneedle Drug Delivery Device Market Value Share, By Product Type, 2020 (E)

Figure 107: Malaysia Microneedle Drug Delivery Device Market Value Share, By End User, 2020 (E)

Figure 108: Australia Microneedle Drug Delivery Device Market Value Share, By Product Type, 2020 (E)

Figure 109: Australia Microneedle Drug Delivery Device Market Value Share, By End User, 2020 (E)

Figure 110: New Zealand Microneedle Drug Delivery Device Market Value Share, By Product Type, 2020 (E)

Figure 111: New Zealand Microneedle Drug Delivery Device Market Value Share, By End User, 2020 (E)

Figure 112: GCC Countries Microneedle Drug Delivery Device Market Value Share, By Product Type, 2020 (E)

Figure 113: GCC Countries Microneedle Drug Delivery Device Market Value Share, By End User, 2020 (E)

Figure 114: Turkey Microneedle Drug Delivery Device Market Value Share, By Product Type, 2020 (E)

Figure 115: Turkey Microneedle Drug Delivery Device Market Value Share, By End User, 2020 (E)

Figure 116: South Africa Microneedle Drug Delivery Device Market Value Share, By Product Type, 2020 (E)

Figure 117: South Africa Microneedle Drug Delivery Device Market Value Share, By End User, 2020 (E)

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[マイクロニードルドラッグデリバリーシステムの世界市場2020年-2030年]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆